Skip to main content

Table 1 Transition probabilities of moving from NESRD state to ESRD state

From: Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis

Cycle

NESRD to ESRD†

NESRD to Death††

ESRD to Death‡

 

moxonidine

nitrendipine

all-cause

Dialysis

Transplant

Dial/Trans 64%/34%

Dial/Trans 50%/50%

1

0.019

0.077

0.0042

0.067

0.013

0.048

0.040

2

0.012

0.053

0.0042

0.067

0.013

0.048

0.040

3

0.013

0.069

0.0042

0.067

0.013

0.048

0.040

4

0.014

0.089

0.0042

0.067

0.013

0.048

0.040

5

0.016

0.118

0.0042

0.067

0.013

0.048

0.040

6

0.017

0.157

0.0042

0.067

0.013

0.048

0.040

  1. †Based on data from Vonend et al 2003.
  2. ††Based on Dutch all-cause mortality 2005 (8.4 per 1,000 inhabitants), (Centraal Bureau voor de Statistiek)
  3. ‡Based on data from ERA EDTA Annual report 2002.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us